Product NDC: | 0173-0442 |
Proprietary Name: | ZOFRAN |
Non Proprietary Name: | ondansetron hydrochloride |
Active Ingredient(s): | 2 mg/mL & nbsp; ondansetron hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0442 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020007 |
Marketing Category: | NDA |
Start Marketing Date: | 19910204 |
Package NDC: | 0173-0442-00 |
Package Description: | 20 mL in 1 VIAL (0173-0442-00) |
NDC Code | 0173-0442-00 |
Proprietary Name | ZOFRAN |
Package Description | 20 mL in 1 VIAL (0173-0442-00) |
Product NDC | 0173-0442 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ondansetron hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19910204 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | ONDANSETRON HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |